Literature DB >> 26865461

Recent Advances on the Role of G Protein-Coupled Receptors in Hypoxia-Mediated Signaling.

Rosamaria Lappano1, Damiano Rigiracciolo1, Paola De Marco1, Silvia Avino1, Anna Rita Cappello1, Camillo Rosano2, Marcello Maggiolini3, Ernestina Marianna De Francesco1.   

Abstract

G protein-coupled receptors (GPCRs) are cell surface proteins mainly involved in signal transmission; however, they play a role also in several pathophysiological conditions. Chemically heterogeneous molecules like peptides, hormones, lipids, and neurotransmitters activate second messengers and induce several biological responses by binding to these seven transmembrane receptors, which are coupled to heterotrimeric G proteins. Recently, additional molecular mechanisms have been involved in GPCR-mediated signaling, leading to an intricate network of transduction pathways. In this regard, it should be mentioned that diverse GPCR family members contribute to the adaptive cell responses to low oxygen tension, which is a distinguishing feature of several illnesses like neoplastic and cardiovascular diseases. For instance, the G protein estrogen receptor, namely G protein estrogen receptor (GPER)/GPR30, has been shown to contribute to relevant biological effects induced by hypoxia via the hypoxia-inducible factor (HIF)-1α in diverse cell contexts, including cancer. Likewise, GPER has been found to modulate the biological outcome of hypoxic/ischemic stress in both cardiovascular and central nervous systems. Here, we describe the role exerted by GPCR-mediated signaling in low oxygen conditions, discussing, in particular, the involvement of GPER by a hypoxic microenvironment.

Entities:  

Keywords:  GPCRs; GPER; angiogenesis; hypoxia; signal transduction

Mesh:

Substances:

Year:  2016        PMID: 26865461      PMCID: PMC4779097          DOI: 10.1208/s12248-016-9881-6

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  94 in total

1.  Functional interactions between mu opioid and alpha 2A-adrenergic receptors.

Authors:  B A Jordan; I Gomes; C Rios; J Filipovska; L A Devi
Journal:  Mol Pharmacol       Date:  2003-12       Impact factor: 4.436

2.  Signaling via GPR30 protects the myocardium from ischemia/reperfusion injury.

Authors:  Brent R Weil; Mariuxi C Manukyan; Jeremy L Herrmann; Yue Wang; Aaron M Abarbanell; Jeffrey A Poynter; Daniel R Meldrum
Journal:  Surgery       Date:  2010-08       Impact factor: 3.982

3.  Insulin-like growth factor-I regulates GPER expression and function in cancer cells.

Authors:  P De Marco; V Bartella; A Vivacqua; R Lappano; M F Santolla; A Morcavallo; V Pezzi; A Belfiore; M Maggiolini
Journal:  Oncogene       Date:  2012-03-19       Impact factor: 9.867

Review 4.  Interplay between receptor tyrosine kinases and hypoxia signaling in cancer.

Authors:  Astrid A Glück; Daniel M Aebersold; Yitzhak Zimmer; Michaela Medová
Journal:  Int J Biochem Cell Biol       Date:  2015-03-06       Impact factor: 5.085

5.  β2-AR-HIF-1α: a novel regulatory axis for stress-induced pancreatic tumor growth and angiogenesis.

Authors:  T Shan; J Ma; Q Ma; K Guo; J Guo; X Li; W Li; J Liu; C Huang; F Wang; E Wu
Journal:  Curr Mol Med       Date:  2013-07       Impact factor: 2.222

Review 6.  Structural and functional analysis of hypoxia-inducible factor 1.

Authors:  G L Semenza; F Agani; G Booth; J Forsythe; N Iyer; B H Jiang; S Leung; R Roe; C Wiener; A Yu
Journal:  Kidney Int       Date:  1997-02       Impact factor: 10.612

Review 7.  The structure and function of G-protein-coupled receptors.

Authors:  Daniel M Rosenbaum; Søren G F Rasmussen; Brian K Kobilka
Journal:  Nature       Date:  2009-05-21       Impact factor: 49.962

8.  GPER1 is regulated by insulin in cancer cells and cancer-associated fibroblasts.

Authors:  Paola De Marco; Enrica Romeo; Adele Vivacqua; Roberta Malaguarnera; Sergio Abonante; Francesco Romeo; Vincenzo Pezzi; Antonino Belfiore; Marcello Maggiolini
Journal:  Endocr Relat Cancer       Date:  2014-07-10       Impact factor: 5.678

9.  Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF.

Authors:  Deo Prakash Pandey; Rosamaria Lappano; Lidia Albanito; Antonio Madeo; Marcello Maggiolini; Didier Picard
Journal:  EMBO J       Date:  2009-01-15       Impact factor: 11.598

10.  Activation of novel estrogen receptor GPER results in inhibition of cardiocyte apoptosis and cardioprotection.

Authors:  Wan-Li Li; Wei Xiang; Ye Ping
Journal:  Mol Med Rep       Date:  2015-04-24       Impact factor: 2.952

View more
  7 in total

Review 1.  Effects of Post-translational Modifications on Membrane Localization and Signaling of Prostanoid GPCR-G Protein Complexes and the Role of Hypoxia.

Authors:  Anurag S Sikarwar; Anjali Y Bhagirath; Shyamala Dakshinamurti
Journal:  J Membr Biol       Date:  2019-09-04       Impact factor: 1.843

Review 2.  GPER-novel membrane oestrogen receptor.

Authors:  Margaret A Zimmerman; Rebecca A Budish; Shreya Kashyap; Sarah H Lindsey
Journal:  Clin Sci (Lond)       Date:  2016-06-01       Impact factor: 6.124

3.  Gpr97 Exacerbates AKI by Mediating Sema3A Signaling.

Authors:  Wei Fang; Ziying Wang; Quanxin Li; Xiaojie Wang; Yan Zhang; Yu Sun; Wei Tang; Chunhong Ma; Jinpeng Sun; Ningjun Li; Fan Yi
Journal:  J Am Soc Nephrol       Date:  2018-03-12       Impact factor: 10.121

Review 4.  Non-canonical Estrogen Signaling in Endocrine Resistance.

Authors:  Prathibha Ranganathan; Namratha Nadig; Sughosha Nambiar
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-16       Impact factor: 5.555

Review 5.  G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging Concepts.

Authors:  Ernestina M De Francesco; Federica Sotgia; Robert B Clarke; Michael P Lisanti; Marcello Maggiolini
Journal:  Int J Mol Sci       Date:  2017-12-14       Impact factor: 5.923

6.  GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.

Authors:  Ernestina M De Francesco; Andrew H Sims; Marcello Maggiolini; Federica Sotgia; Michael P Lisanti; Robert B Clarke
Journal:  Breast Cancer Res       Date:  2017-12-06       Impact factor: 6.466

7.  The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).

Authors:  Rosamaria Lappano; Marianna Talia; Francesca Cirillo; Damiano Cosimo Rigiracciolo; Domenica Scordamaglia; Rita Guzzi; Anna Maria Miglietta; Ernestina Marianna De Francesco; Antonino Belfiore; Andrew H Sims; Marcello Maggiolini
Journal:  J Exp Clin Cancer Res       Date:  2020-08-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.